Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Why Bausch (BHC) is Poised to Beat Earnings Estimates Again

Bausch (BHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

BHC : 29.25 (-1.15%)
Salix Announces 2021 Gastrointestinal Health Scholars Program Winners

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Ardelyx (ARDX) Tumbles Following Deficiencies in Tenapanor NDA

The FDA notes deficiencies in the NDA seeking approval for Ardelyx's (ARDX) lead pipeline candidate, tenapanor, as a potential treatment for hyperphosphatemia.

IRWD : 13.27 (+0.84%)
ABBV : 116.30 (-2.16%)
ARDX : 1.7400 (+1.75%)
BHC : 29.25 (-1.15%)
Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refractive Surgery

/PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the presentation of 14 scientific posters involving...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes

/PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the U.S. launch of Biotrue Hydration Boost Lubricant...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
4 Healthcare Stocks to Buy for Growth and Value

Bausch Health Companies (BHC), Regeneron Pharmaceuticals (REGN), Orthofix Medical (OFIX), and Alkermes (ALKS) are 4 healthcare stocks with strong value and growth qualities. These are a good fit for the...

REGN : 574.61 (-1.46%)
BHC : 29.25 (-1.15%)
OFIX : 39.74 (+1.53%)
ALKS : 25.87 (+1.21%)
Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03 (perfluorohexyloctane)

and , , /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), and Novaliq GmbH, a biopharmaceutical company...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter 2021 financial results on . Bausch Health will host a conference call and live web cast at...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by through the redemption of outstanding senior notes, using cash generated...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses

 New Parameters Provide a Broader Offering for Presbyopic Patients with Astigmatism , QB, /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX:...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch Health Announces Extension Of Its Tender Offer For Cash Tender Offer For Senior Secured Notes By One Business Day To Reflect The Federal Holiday On June 18, 2021

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC)("Bausch Health," the "Company" or the "Offeror") today announced that it has extended the expiration date for its previously announced cash...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that D. has resigned from his role as an independent director of the Company's Board of...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE™ Clinical Decision Support Software

QB and , /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that its affiliate has entered into an agreement...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer For Senior Secured Notes

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today the results to date of its pending cash tender offer (the "Tender O�EUR...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension)

and , /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Bausch + Lomb, its leading global eye health business, along with Clearside Biomedical, Inc. (Nasdaq: CLSD) ("Clearside"),...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
CLSD : 4.92 (-5.57%)
Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month

and , /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Prevent Blindness, the nation's oldest volunteer eye health...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by through the redemption of outstanding senior notes, using cash...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch Health Announces Participation At The Jefferies Healthcare Conference

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that , chairman and chief executive officer; , senior vice president and corporate controller;...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced its previously announced offering of aggregate principal amount of...

BHC : 29.25 (-1.15%)
BHC.TO : 36.50 (-1.00%)

Barchart Exclusives

When Weather and Weather Derivatives Diverge
A look at the softs complex Friday morning shows us markets aren't looking at weather in Brazil to close out the month. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar